Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative dexmedetomidine for prevention of postoperative cognitive dysfunction in elderly patients undergoing major surgery
ChiCTR1800017454Phase 4Not yet recruiting
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in post-operative cognitive decline (POCD) comparing Dexmedetomidine group with Placebo (2 arms). Primary endpoints: Mini-mental State Examination, Digit Span Test and 2 more. Planned start Sep 2018; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
post-operative cognitive decline (POCD)
Beyond the preview
Go deeper on ChiCTR1800017454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800017454.